SparX Group
Grand Cayman
About SparX Group
SparX Group is a biotech firm that develops innovative anticancer biologics through bispecific antibodies and drug conjugates.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $30.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2021)
Industries & Categories
Biopharma, Biotechnology, Health Care
Canonical: https://fsome.com/organization/sparx-group-45313 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.